The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

BROKER RATINGS: Bank of America double upgrades Morrisons to Buy

Thu, 17th Jun 2021 09:36

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

CITIGROUP RAISES INTERMEDIATE CAPITAL PRICE TARGET TO 2,534 (2,368) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1,800 (1,890) PENCE - 'BUY'

----------

UBS RAISES ASTRAZENECA PRICE TARGET TO 9,200 (8,000) PENCE - 'BUY'

----------

FTSE 250

----------

BOFA RAISES WM MORRISON SUPERMARKETS TO 'BUY' ('UNDERPERFORM') - TARGET 210 PENCE

----------

UBS RAISES MONEYSUPERMARKET.COM PRICE TARGET TO 345 (340) PENCE - 'BUY'

----------

GOLDMAN RAISES DR MARTENS PRICE TARGET TO 490 (480) PENCE - 'NEUTRAL'

----------

BERENBERG RAISES OXFORD INSTRUMENTS PRICE TARGET TO 2,580 (2,465) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS HISCOX PRICE TARGET TO 990 (1,035) PENCE - 'OUTPERFORM'

----------

CREDIT SUISSE RAISES ROYAL MAIL PRICE TARGET TO 647 (284) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES MAN GROUP PRICE TARGET TO 240 (220) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES 888 HOLDINGS PRICE TARGET TO 460 (440) PENCE - 'BUY'

----------

LIBERUM RAISES PETS AT HOME TO 'BUY' ('HOLD') - TARGET 510 (460) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

JEFFERIES RAISES KEYWORDS STUDIOS PRICE TARGET TO 3,450 (3,382) PENCE - 'BUY'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.